Overexpression of ESRP1 and/or ESRP2 has been described in various malignant tumors, such as pancreatic ductal adenocarcinoma, oral squamous carcinoma, ovarian cancer, and luminal-type breast cancer [8–12]. This evidence concerns the gene ESRP2 and ovarian cancer.